(Q44567179)

4 December 2017

title

Effects of plasmid-mediated growth hormone-releasing hormone supplementation on LL-2 adenocarcinoma in mice (English)

1 reference

4 December 2017

1 reference

Amir S Khan

1

1 reference

4 December 2017

Ingrid W Anscombe

2

1 reference

4 December 2017

Kathleen K Cummings

3

1 reference

4 December 2017

Melissa A Pope

4

1 reference

4 December 2017

Louis C Smith

5

1 reference

4 December 2017

Ruxandra Draghia-Akli

6

1 reference

4 December 2017

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

8

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

459-466

1 reference

Neuroendocrine control of growth hormone secretion

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Insulin-like growth factor 1 (IGF-1): a growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

The growth hormone axis: control and effects

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Growth hormone signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Insulin-like growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

1 reference

7 January 2021

Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Effects of plasmid-mediated growth hormone-releasing hormone in severely debilitated dogs with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Nonhereditary enhancement of progeny growth

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Does the GH-IGF axis play a role in cancer pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

A risk-benefit assessment of growth hormone use in children

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Growth hormone administration after treatment in the resistant hepatocyte model does not affect progression of rat liver carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Risk of leukemia after treatment with pituitary growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Treatment of cachexia with recombinant growth hormone in a patient before lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Effect of chronic growth hormone administration on skeletal muscle in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Effect of growth hormone and protein intake on tumor growth and host cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Immune enhancing effect of a growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Aging and immune function: a possible role for growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Skeletal muscle fiber, nerve, and blood vessel breakdown in space-flown rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Role of hormones in the pathogenesis and management of sarcopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Therapies for improving muscle function in neuromuscular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Erythropoiesis, serum erythropoietin, and serum IGF-I in rats during accelerated growth

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

The growth hormone-insulin-like growth factor axis in kidney re-revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

Insulin-like growth factor-I treatment to enhance renal function in advanced chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900175-8

7 January 2021

10.1016/S1525-0016(03)00175-8

Identifiers

DOI

1 reference

4 December 2017

1 reference